Header Logo

Gary Schaer

Concepts (313)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myocardial Infarction
22
2022
129
2.310
Why?
Angioplasty, Balloon, Coronary
17
2022
36
2.210
Why?
ST Elevation Myocardial Infarction
3
2022
9
1.520
Why?
Percutaneous Coronary Intervention
3
2022
24
1.330
Why?
Coronary Restenosis
5
2015
11
1.170
Why?
Stents
11
2004
80
1.040
Why?
Antigens, CD34
6
2018
12
0.970
Why?
Stem Cell Transplantation
5
2018
38
0.950
Why?
Cicatrix
1
2022
7
0.820
Why?
Nanoparticles
1
2022
11
0.820
Why?
No-Reflow Phenomenon
1
2022
1
0.790
Why?
Electrocardiography
6
2015
101
0.780
Why?
Brachytherapy
5
2004
51
0.750
Why?
Myocardial Ischemia
3
2017
37
0.720
Why?
Myocardium
9
2018
95
0.670
Why?
Cardiac Catheterization
4
2017
61
0.630
Why?
MicroRNAs
2
2015
52
0.590
Why?
Triage
2
2015
18
0.580
Why?
Drug-Eluting Stents
2
2015
15
0.570
Why?
Heart Injuries
1
2017
2
0.570
Why?
Body Surface Potential Mapping
1
2017
3
0.570
Why?
Stem Cells
4
2022
40
0.570
Why?
Heart Aneurysm
1
2017
8
0.560
Why?
Heart Failure, Systolic
1
2016
6
0.550
Why?
Heart Ventricles
1
2017
96
0.530
Why?
Cell- and Tissue-Based Therapy
4
2016
12
0.530
Why?
Angina Pectoris
5
2018
13
0.530
Why?
Humans
51
2022
25692
0.520
Why?
Emergency Service, Hospital
4
2015
245
0.520
Why?
Vascular Remodeling
1
2015
4
0.500
Why?
Vascular System Injuries
1
2015
5
0.500
Why?
Catheters
2
2021
17
0.460
Why?
Early Diagnosis
1
2014
60
0.460
Why?
Coronary Angiography
7
2022
67
0.450
Why?
Hematopoietic Stem Cells
1
2012
9
0.420
Why?
Needles
1
2012
12
0.420
Why?
Inpatients
1
2014
132
0.410
Why?
Ventricular Dysfunction, Left
3
2016
39
0.410
Why?
Ventricular Function, Left
6
2016
36
0.400
Why?
Middle Aged
32
2018
8403
0.390
Why?
Animals
12
2022
3510
0.380
Why?
Hematopoietic Stem Cell Transplantation
1
2012
95
0.380
Why?
Male
38
2018
13917
0.370
Why?
Platelet Aggregation Inhibitors
2
2016
48
0.360
Why?
Heart Failure
4
2016
166
0.360
Why?
Graft Occlusion, Vascular
3
2004
19
0.340
Why?
Coronary Stenosis
3
2004
16
0.340
Why?
Treatment Outcome
22
2021
3231
0.340
Why?
Myocardial Revascularization
3
2004
15
0.330
Why?
Coronary Disease
5
2003
56
0.330
Why?
Time Factors
10
2016
1336
0.320
Why?
Aged
26
2018
8501
0.320
Why?
Strontium Radioisotopes
3
2003
7
0.310
Why?
Female
31
2018
14273
0.310
Why?
Poloxalene
4
1996
4
0.300
Why?
Transplantation, Autologous
6
2018
151
0.290
Why?
Follow-Up Studies
14
2015
1689
0.280
Why?
Cardiomyopathy, Dilated
3
2016
7
0.280
Why?
Laser Therapy
2
2004
10
0.280
Why?
Gastric Fundus
1
2006
2
0.280
Why?
Gastric Fistula
1
2006
5
0.270
Why?
Coronary Artery Disease
5
2016
126
0.270
Why?
Electrodes
1
2006
12
0.270
Why?
Pericardium
1
2006
18
0.270
Why?
Defibrillators, Implantable
1
2006
9
0.270
Why?
Myocardial Reperfusion
3
1996
5
0.250
Why?
Double-Blind Method
10
2016
396
0.240
Why?
Myocardial Reperfusion Injury
3
1995
8
0.240
Why?
Platelet Membrane Glycoprotein IIb
1
2004
1
0.240
Why?
Integrin beta3
1
2004
3
0.240
Why?
Myocardial Stunning
1
2004
2
0.230
Why?
Heart Transplantation
1
2004
29
0.230
Why?
Blood Platelets
1
2004
36
0.230
Why?
Embolism, Cholesterol
1
2004
1
0.230
Why?
Vascular Diseases
1
2004
40
0.230
Why?
Echocardiography
3
2017
88
0.220
Why?
Vascular Endothelial Growth Factor A
2
2022
68
0.210
Why?
Adrenal Cortex Hormones
1
2004
102
0.210
Why?
Exercise Tolerance
3
2018
30
0.210
Why?
Receptors, Fc
1
2022
9
0.210
Why?
Complement Activation
1
2022
10
0.210
Why?
Epitopes
1
2022
44
0.200
Why?
Blood Substitutes
3
1995
3
0.200
Why?
Fluorocarbons
3
1995
11
0.200
Why?
Echocardiography, Doppler
2
2001
21
0.200
Why?
Heart
2
1994
57
0.200
Why?
Macrophages
1
2022
97
0.200
Why?
Atherectomy, Coronary
1
2021
2
0.190
Why?
Mammary Arteries
1
2021
4
0.190
Why?
Wound Healing
1
2022
150
0.190
Why?
Cytokines
1
2022
212
0.180
Why?
Thrombolytic Therapy
2
2002
48
0.180
Why?
Mice
2
2022
1345
0.170
Why?
Prospective Studies
11
2016
1633
0.170
Why?
Swine
2
2012
71
0.160
Why?
Genetic Therapy
2
2013
75
0.150
Why?
Marital Status
1
2018
7
0.150
Why?
Angioplasty, Balloon
5
2004
13
0.150
Why?
Clinical Trials as Topic
3
2016
209
0.150
Why?
Mortality
1
2018
80
0.150
Why?
Injections, Intramuscular
2
2018
7
0.140
Why?
Radionuclide Ventriculography
1
2017
1
0.140
Why?
Diagnosis, Differential
2
2017
341
0.140
Why?
Bone Marrow Transplantation
1
2016
22
0.140
Why?
Endothelial Progenitor Cells
1
2016
1
0.140
Why?
Blood Vessel Prosthesis Implantation
4
2004
21
0.140
Why?
Cardiomyopathies
1
2016
28
0.130
Why?
Dogs
7
1996
176
0.130
Why?
Imaging, Three-Dimensional
1
2017
217
0.130
Why?
Oxygen Inhalation Therapy
1
1995
18
0.130
Why?
Muscle, Smooth, Vascular
1
2015
6
0.120
Why?
Myocytes, Smooth Muscle
1
2015
7
0.120
Why?
Blood Cells
1
2015
4
0.120
Why?
Hospital Design and Construction
1
2015
5
0.120
Why?
Stroke Volume
4
2002
49
0.120
Why?
Coronary Circulation
5
1996
25
0.120
Why?
Patient Transfer
1
2014
22
0.120
Why?
Beta Particles
3
2003
6
0.120
Why?
Atherosclerosis
1
2015
55
0.120
Why?
Gene Transfer Techniques
2
2005
25
0.110
Why?
Mesenchymal Stem Cell Transplantation
2
2016
30
0.110
Why?
Equipment Design
2
2012
139
0.110
Why?
Referral and Consultation
1
2014
86
0.110
Why?
Biomarkers
2
2016
554
0.110
Why?
Fibrinolytic Agents
4
2010
53
0.110
Why?
Angina, Stable
1
2013
2
0.110
Why?
Retrospective Studies
3
2015
3220
0.110
Why?
Chemokine CXCL12
1
2013
10
0.110
Why?
Plasmids
1
2013
37
0.110
Why?
Tomography, X-Ray Computed
3
2006
698
0.100
Why?
Treatment Failure
2
2003
154
0.100
Why?
Radiography, Interventional
1
2012
22
0.100
Why?
Microscopy, Fluorescence
1
2012
71
0.100
Why?
Fluoroscopy
1
2012
45
0.100
Why?
Cell Survival
1
2012
110
0.100
Why?
Models, Animal
1
2012
110
0.100
Why?
Radiography
2
2004
574
0.100
Why?
Randomized Controlled Trials as Topic
3
2018
311
0.100
Why?
Exercise Test
3
2016
103
0.100
Why?
Length of Stay
1
2014
300
0.100
Why?
Early Medical Intervention
1
2012
13
0.100
Why?
Immunohistochemistry
1
2012
341
0.100
Why?
Combined Modality Therapy
5
2004
281
0.100
Why?
Registries
2
2010
170
0.090
Why?
Patient Care Team
1
2012
130
0.090
Why?
Product Surveillance, Postmarketing
1
2010
9
0.090
Why?
Sirolimus
1
2010
18
0.080
Why?
Adult
11
2016
7336
0.080
Why?
Severity of Illness Index
2
2004
913
0.080
Why?
Thoracotomy
2
2006
25
0.080
Why?
Disease Models, Animal
3
2004
584
0.080
Why?
Immunosuppressive Agents
1
2010
124
0.080
Why?
Vascular Endothelial Growth Factors
2
2005
12
0.070
Why?
Injections
3
2013
43
0.070
Why?
Collateral Circulation
3
1999
5
0.070
Why?
Magnetic Resonance Imaging
1
2012
1084
0.070
Why?
Stroke
2
2016
259
0.070
Why?
Pilot Projects
3
2004
392
0.070
Why?
Risk Assessment
3
2004
618
0.070
Why?
Radiography, Thoracic
1
2006
25
0.070
Why?
Equipment Failure
1
2006
38
0.070
Why?
Foreign-Body Migration
1
2006
18
0.070
Why?
Device Removal
1
2006
85
0.070
Why?
Renal Circulation
1
1985
2
0.060
Why?
Survival Rate
2
2004
308
0.060
Why?
Tryptamines
1
2005
1
0.060
Why?
Oxazolidinones
1
2005
1
0.060
Why?
Practice Guidelines as Topic
2
2004
284
0.060
Why?
Norepinephrine
1
1985
27
0.060
Why?
Migraine Disorders
1
2005
19
0.060
Why?
Dopamine
1
1985
85
0.060
Why?
Infusions, Intravenous
3
2009
49
0.060
Why?
Peripheral Vascular Diseases
1
2004
6
0.060
Why?
Ischemia
1
2004
19
0.060
Why?
Extremities
1
2004
23
0.060
Why?
Neutrophils
2
1995
89
0.060
Why?
Thromboembolism
1
2004
17
0.060
Why?
Predictive Value of Tests
2
2003
443
0.060
Why?
Ultrasonography, Doppler
1
2004
13
0.060
Why?
Radiology, Interventional
1
2004
6
0.060
Why?
Calcinosis
1
2004
48
0.060
Why?
Risk Factors
2
2016
2224
0.060
Why?
Lower Extremity
1
2004
39
0.060
Why?
United States
3
2016
1943
0.060
Why?
Hematologic Agents
1
2003
3
0.060
Why?
Single-Blind Method
1
2004
104
0.060
Why?
Angina, Unstable
1
2003
10
0.060
Why?
Acute Disease
1
2004
187
0.060
Why?
Lymphokines
1
2003
7
0.060
Why?
Endothelial Growth Factors
1
2003
8
0.060
Why?
Saphenous Vein
1
2003
4
0.050
Why?
Brain Ischemia
1
2004
58
0.050
Why?
Coronary Vessels
2
2016
33
0.050
Why?
Rhodotorula
1
2003
1
0.050
Why?
DNA
1
2003
95
0.050
Why?
Endpoint Determination
1
2003
21
0.050
Why?
Heart Valve Prosthesis
1
2003
12
0.050
Why?
Endocarditis, Bacterial
1
2003
10
0.050
Why?
Mycoses
1
2003
21
0.050
Why?
Statistics as Topic
1
2003
110
0.050
Why?
Intercellular Signaling Peptides and Proteins
1
2003
52
0.050
Why?
Incidence
2
2003
731
0.050
Why?
Necrosis
2
1994
25
0.050
Why?
Death
1
2003
35
0.050
Why?
Hypothermia, Induced
1
2002
15
0.050
Why?
Illinois
1
2003
223
0.050
Why?
Recurrence
1
2003
275
0.050
Why?
Multivariate Analysis
1
2003
299
0.050
Why?
Transplantation, Homologous
1
2003
248
0.050
Why?
Aged, 80 and over
5
2016
4459
0.050
Why?
Diastole
1
2001
27
0.050
Why?
Neovascularization, Physiologic
2
2016
19
0.050
Why?
Postoperative Complications
2
2004
827
0.050
Why?
Surface-Active Agents
2
1999
5
0.040
Why?
Technetium Tc 99m Sestamibi
2
1999
11
0.040
Why?
Quality of Life
2
2016
600
0.040
Why?
Kaplan-Meier Estimate
1
2018
157
0.040
Why?
Cardiology Service, Hospital
1
1997
2
0.040
Why?
Cardiovascular Agents
2
2012
27
0.040
Why?
Endothelin-1
1
1996
3
0.030
Why?
Infusions, Intra-Arterial
1
2016
1
0.030
Why?
Early Termination of Clinical Trials
1
2016
1
0.030
Why?
Practice Patterns, Physicians'
1
1997
107
0.030
Why?
Placebos
1
1996
68
0.030
Why?
Salvage Therapy
1
1996
36
0.030
Why?
Drug Therapy, Combination
1
2016
163
0.030
Why?
Hemorrhage
1
2016
75
0.030
Why?
Risk
1
2016
190
0.030
Why?
Academic Medical Centers
2
2012
119
0.030
Why?
Clinical Competence
1
1997
217
0.030
Why?
Recovery of Function
1
2016
255
0.030
Why?
Chemotaxis, Leukocyte
1
1994
9
0.030
Why?
Gases
1
1994
5
0.030
Why?
Hospitals, Community
1
2014
12
0.030
Why?
Hospitals, University
1
2014
25
0.030
Why?
Ventricular Fibrillation
1
1994
13
0.030
Why?
Rats, Sprague-Dawley
1
2015
322
0.030
Why?
Time-to-Treatment
1
2014
34
0.030
Why?
Mice, Knockout
1
2015
284
0.030
Why?
Cooperative Behavior
1
2014
74
0.030
Why?
Patient-Centered Care
1
2014
51
0.030
Why?
Cells, Cultured
1
2015
495
0.030
Why?
Mice, Inbred C57BL
1
2015
405
0.030
Why?
Rats
1
2015
649
0.030
Why?
Natriuretic Peptide, Brain
1
2013
10
0.030
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
2
2003
7
0.030
Why?
Angioplasty, Balloon, Laser-Assisted
1
1992
1
0.030
Why?
Peptide Fragments
1
2013
71
0.030
Why?
Positron-Emission Tomography
1
2013
84
0.030
Why?
Dose-Response Relationship, Drug
1
2013
325
0.020
Why?
Delayed Diagnosis
1
2012
10
0.020
Why?
Logistic Models
2
2004
366
0.020
Why?
Critical Pathways
1
2012
20
0.020
Why?
Clinical Protocols
1
2012
53
0.020
Why?
Guideline Adherence
1
2012
59
0.020
Why?
Disease Management
1
2012
97
0.020
Why?
Survival Analysis
2
2002
246
0.020
Why?
Quality Improvement
1
2012
132
0.020
Why?
Off-Label Use
1
2010
6
0.020
Why?
Quality Control
1
2010
32
0.020
Why?
Injections, Intra-Arterial
1
1989
5
0.020
Why?
Diabetes Mellitus, Type 1
1
2010
23
0.020
Why?
Prednisone
1
1989
58
0.020
Why?
Cohort Studies
1
2013
1781
0.020
Why?
Streptokinase
1
1987
1
0.020
Why?
Young Adult
1
2013
1855
0.020
Why?
Shock, Septic
1
1986
57
0.020
Why?
Infusions, Parenteral
1
1985
9
0.020
Why?
Cardiac Output
1
1985
11
0.020
Why?
Vascular Resistance
1
1985
10
0.020
Why?
Drug Combinations
1
1985
34
0.020
Why?
Serotonin Receptor Agonists
1
2005
4
0.020
Why?
Heart Rate
1
1985
109
0.010
Why?
Chi-Square Distribution
1
2004
126
0.010
Why?
Blood Pressure
1
1985
185
0.010
Why?
Economics, Pharmaceutical
1
2003
3
0.010
Why?
Factor Xa Inhibitors
1
2003
5
0.010
Why?
Aortic Valve
1
2003
25
0.010
Why?
Antifungal Agents
1
2003
43
0.010
Why?
Safety
1
2002
40
0.010
Why?
Feasibility Studies
1
2002
207
0.010
Why?
Radionuclide Angiography
1
2002
1
0.010
Why?
Manometry
1
2001
14
0.010
Why?
Random Allocation
1
2002
116
0.010
Why?
Hypertrophy, Left Ventricular
1
2001
16
0.010
Why?
Hemodynamics
1
2001
57
0.010
Why?
Tomography, Emission-Computed, Single-Photon
1
2002
69
0.010
Why?
Patient Dropouts
1
2000
22
0.010
Why?
Poloxamer
1
1999
3
0.010
Why?
Computer Systems
1
1999
7
0.010
Why?
Radionuclide Imaging
1
1999
38
0.010
Why?
Prognosis
1
2002
739
0.010
Why?
Reoperation
1
2003
818
0.010
Why?
Credentialing
1
1997
7
0.010
Why?
Hospitals, Urban
1
1997
31
0.010
Why?
Coronary Artery Bypass
1
1997
26
0.010
Why?
Health Services Research
1
1997
38
0.010
Why?
Odds Ratio
1
1997
244
0.010
Why?
Hospital Mortality
1
1997
131
0.010
Why?
Creatinine
1
1996
47
0.010
Why?
Rabbits
1
1995
184
0.010
Why?
Chicago
1
1997
869
0.010
Why?
Fibroblasts
1
1989
55
0.010
Why?
Lymphocytes
1
1989
57
0.010
Why?
Drug Administration Schedule
1
1989
152
0.010
Why?
Angiography
1
1987
29
0.000
Why?
Anemia, Aplastic
1
1986
1
0.000
Why?
Regional Blood Flow
1
1986
8
0.000
Why?
Lactates
1
1986
3
0.000
Why?
Oxygen Consumption
1
1986
45
0.000
Why?
Acquired Immunodeficiency Syndrome
1
1986
41
0.000
Why?
Neoplasms
1
1986
224
0.000
Why?
Adolescent
1
1986
2076
0.000
Why?
Schaer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (313)
Explore
_
Co-Authors (11)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_